Clinical Trial Update: Sphenopalatine Ganglion Block for Post-Dural Puncture Headache [NA]

View source ↗

Summary

Clinical trial on sphenopalatine ganglion block for postdural puncture headache has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postdural Puncture Headache

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Postdural Puncture Headache, Sphenopalatine Ganglion Block | NA | Status: WITHDRAWN